Freezing an ovary means stiffening it: a potential avenue for preserving dormant follicles

The phase structure is well organised, with explicit GO/NO-GO/PIVOT criteria, enabling objective decision-making and protocol adaptation during the course of the study — an approach that is both rare and rigorous.

The hypothesis proposes a mechanism that is both innovative and mechanistically plausible, linking post-cryopreservation matrix stiffness to follicular activation via the YAP/TAZ-Notch pathway. This constitutes a significant conceptual advance relative to existing models centred on the PI3K/AKT and mTOR pathways.

The hypothesis addresses a clinically relevant problem (loss of follicle reserve after cryopreservation) and proposes a testable mechanotransduction-based intervention.

A clearly identified niche market: the preservation of female fertility (oncofertility) is a rapidly growing segment, with actors such as OvaScience (now absorbed), Ferring Pharmaceuticals, and assisted reproduction clinics (e.g., IVI, Clinica Eugin). The clinical need is genuine: pre-pubescent patients or those unable to undergo ovarian stimulation have only ovarian tissue cryopreservation as an option, and post-thaw follicular loss is a major problem.

A clear and testable mechanistic hypothesis is proposed, with a direct causal link between a measurable physical modification (ECM stiffness) and a fundamental biological process (follicle activation). This aligns perfectly with the expectations of exploratory programmes such as the ERC.